Plain-English translation of NCT06662786 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Neoplasms research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial compares two different treatment approaches for advanced colorectal cancer. You would receive either —a new medication designed to target cancer cells—or (a standard treatment), both combined with chemotherapy drugs. The study will measure how long people stay free of cancer growth with each approach.
Current treatments for this type of advanced colorectal cancer have limits in how long they keep cancer from growing. Researchers believe this medication may work better than the standard option when paired with chemotherapy, potentially giving patients more time before their cancer progresses.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new medication or the standard medication, both combined with one of two chemotherapy regimens, given in 28-day treatment cycles. You will continue treatment until your cancer grows on imaging, you experience unacceptable side effects, or another stopping point is reached. Throughout the study, you will have regular clinic visits for blood work, scans, and physical exams to monitor how well the treatment is working and track any side effects.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States